Company / Capital Expenditures
bioAffinity Technologies, Inc. Capital Expenditures History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$79.1K
FY2025
5-year range
$22.9K / $220.0K
FY2022-FY2025
Trend
+245.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures changed +245% YoY in FY2025, a notable deviation from the 3-year average annual change of +52%.
Based on SEC 10-K filings.
$79,083 in FY2025 with a 3-year CAGR of -28.9%.
Declined from $219,987 to $79,083 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -28.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -28.9%, indicating a declining trend.
- In FY2025, capital expenditures increased 245.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $79.1K | +245.3% |
| FY2024 | $22.9K | -89.6% |
| FY2023 | $220.0K | +0.0% |
| FY2022 | $220.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026